Doctor / Hospital Address Book
Sponsored By
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
Please Click On The Above Banner For More Details
Braintumor Website


Name:   Clinical Trials Office - University of Wisconsin
Title:  
Facility: University of Wisconsin Comprehensive Cancer Center 
Location: Madison, WI USA
Phone: 608-262-5223
Fax:
Email: Email not available
Website:


Name:  Diane Puccetti MD
Title:  
Facility: University of Wisconsin Comprehensive Cancer Center 
Location: Madison, WI USA
Phone: 608-263-0320
Fax:
Email: Email not available
Website:

There are 4 listings:
  Treatment Location Last Updated
Details Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Madison, WI 09/22/2012
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Madison, WI 03/03/2011
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Madison, WI 04/15/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Madison, WI 04/11/2008




Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites